Status:
COMPLETED
COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)
Lead Sponsor:
Luxembourg Institute of Health
Collaborating Sponsors:
Luxembourg National Research Funds
University of Luxembourg
Conditions:
COVID19
Eligibility:
All Genders
18+ years
Brief Summary
CON-VINCE (COvid-19 National survey for assessing VIral spread by Non-affected CarriErs) is a national, monocentric, and longitudinal study aiming to evaluate the spread dynamics of the COVID-19 disea...
Detailed Description
To capture the dynamics and impact of the virus spread in the Luxembourgish population, data and sample collection is done every two weeks for two months (4 times in total) with a final follow-up one ...
Eligibility Criteria
Inclusion
- Subjects aged 18 and older of both genders, with a full capacity of consent.
- SARS-CoV-2-positive individuals with an asymptomatic or oligosymptomatic infection (mild or oligosymptomatic disease course is defined as absence of fever and respiratory distress or cough not attributable to other known chronic disease).
- OR SARS-CoV-2-negative individuals at the time of inclusion.
- OR post-infectious SARS-CoV-2-negative individuals with acquired immunity to SARS-CoV-2 and a mild disease course.
Exclusion
- Evolution of the COVID-19 disease requiring a hospital admission before inclusion in the study
- Presence of fever and respiratory distress/cough at the time of inclusion not attributable to other known chronic disease
Key Trial Info
Start Date :
April 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
1870 Patients enrolled
Trial Details
Trial ID
NCT04379297
Start Date
April 10 2020
End Date
September 30 2022
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luxembourg Institute of Health
Strassen, Luxembourg, 1445